secwatch.observer — SEC 8-K summary
======================================

Issuer:     CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK:        0001369568
Form:       8-K
Filed at:   2026-07-08T21:29:46+00:00
Accession:  0001193125-26-298739
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Catalyst shareholders approve merger with Angelini Pharma; all directors to resign at closing
--------------------------------------------------------------------------------

- Stockholders approved merger with Angelini Pharma: 97,340,180 votes for, 1,143,815 against, 242,616 abstentions.
- Advisory compensation proposal for named executive officers not approved (30.5M for, 67.5M against); non-binding and not a condition to merger.
- All seven directors (McEnany, Daly, Curran, Denkhaus, Harper, Thompson, Tierney) to resign effective at merger closing; no disagreement with company.
- Merger closing subject to customary conditions; no expected closing date provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369568/000119312526298739/0001193125-26-298739-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369568/000119312526298739/d109692d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-298739

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer